Abstract
Coronavirus-19 is a severe acute respiratory disorder in humans which has become a major health problem. It spreads out very rapidly throughout the world since it has been first identified in Wuhan, China (December 2019). The causative virus is known as severe acute respiratory syndrome coronavirus 2. And the World Health Organization has named this respiratory syndrome as a new epidemic disease called COVID-19. The incidence of COVID-19 continued to increase with three million confirmed infected cases and with 244,000 death cases worldwide. Until now there is no specific treatment or vaccine available against COVID- 19. The collective information about the different aspects of COVID-19 viral infection has been gathered from renowned journals, and electronic databases including Science Direct, Web of Science, Scopus and PubMed from 1990 to 2020. This manuscript has highlighted the transmission and symptoms of Covid-19. Therefore, these studies show how the SARS-CoV 2 can facilitate the debut of the virus into targeted host cells.
Keywords: Coronavirus, ACE2, replication, target, protein, spike.
Graphical Abstract
Current Pharmaceutical Biotechnology
Title:Pathogenesis of COVID-19, Disease Outbreak: A Review
Volume: 22 Issue: 12
Author(s): Himanshu Sharma*, Sonia Singh and Shilpi Pathak
Affiliation:
- Department of Computer Engineering & Applications GLA University, 17km Stone, NH-2, Mathura-Delhi Road Mathura, Chaumuhan, Uttar Pradesh-281406,India
Keywords: Coronavirus, ACE2, replication, target, protein, spike.
Abstract: Coronavirus-19 is a severe acute respiratory disorder in humans which has become a major health problem. It spreads out very rapidly throughout the world since it has been first identified in Wuhan, China (December 2019). The causative virus is known as severe acute respiratory syndrome coronavirus 2. And the World Health Organization has named this respiratory syndrome as a new epidemic disease called COVID-19. The incidence of COVID-19 continued to increase with three million confirmed infected cases and with 244,000 death cases worldwide. Until now there is no specific treatment or vaccine available against COVID- 19. The collective information about the different aspects of COVID-19 viral infection has been gathered from renowned journals, and electronic databases including Science Direct, Web of Science, Scopus and PubMed from 1990 to 2020. This manuscript has highlighted the transmission and symptoms of Covid-19. Therefore, these studies show how the SARS-CoV 2 can facilitate the debut of the virus into targeted host cells.
Export Options
About this article
Cite this article as:
Sharma Himanshu *, Singh Sonia and Pathak Shilpi, Pathogenesis of COVID-19, Disease Outbreak: A Review, Current Pharmaceutical Biotechnology 2021; 22 (12) . https://dx.doi.org/10.2174/1389201022666210127113441
DOI https://dx.doi.org/10.2174/1389201022666210127113441 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Recovery of an Elderly Woman with Asthma and Diabetes from
COVID-19 Infection: A Case Report
Infectious Disorders - Drug Targets Impact of Coronavirus Outbreak on Climate and Air Quality
Current Signal Transduction Therapy Alterations in Clinical Characteristics of Blood Donors Post COVID-19 Recovery
Current Pharmaceutical Design Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARSCoV-2 Replication by Inhibiting its M<sup>PRO</sup> Main Protease
Current Pharmaceutical Biotechnology Synthetic Lung Surfactant Treatment for COVID-19 Pneumonia
Coronaviruses COVID-19: A Daily Dose of Yoga to Cope with Anxiety
Coronaviruses Clinical Characteristics of Inpatients with Coronavirus Disease 2019 and Acute Ischemic Stroke: From Epidemiology to Outcomes
Current Neurovascular Research Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Current Pharmaceutical Design Biological Importance, Therapeutic Benefit and Analytical Aspects of Bioactive Flavonoid Pectolinarin in the Nature
Drug Metabolism Letters Advances of Inorganic Materials in the Detection and Therapeutic Uses against Coronaviruses
Current Medicinal Chemistry Properties of Ethnomedicinal Plants and Their Bioactive Compounds: Possible Use for COVID-19 Prevention and Treatment
Current Pharmaceutical Design Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target
Current Medicinal Chemistry Mass Spectrometry, Proteomics, Data Mining Strategies and Their Applications in Infectious Disease Research.
Anti-Infective Agents in Medicinal Chemistry COVID-19 Epigenetics and Implications for Public Health
Coronaviruses Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital
Infectious Disorders - Drug Targets SARS-CoV-2: Origin, Pathogenesis and Therapeutic Interventions
Coronaviruses Nanotechnology-based Approaches for COVID-19: A Path Forward
Current Nanomaterials Broadening Our View of Protective Antibody Responses Against HIV
Current HIV Research A Mini Review on COVID-19 Therapeutics: Current Status and Future Directions
Coronaviruses COVID-19: Innovative Antiviral Drugs Required for Long-Term Prevention and Control of Coronavirus Diseases
Current Medicinal Chemistry